PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.07%
Revenue growth at 50-75% of ADI's 1.49%. Martin Whitman would worry about competitiveness or product relevance.
-6.06%
Negative gross profit growth while ADI is at 1.46%. Joel Greenblatt would examine cost competitiveness or demand decline.
-10.44%
Negative EBIT growth while ADI is at 2.55%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-10.44%
Negative operating income growth while ADI is at 2.55%. Joel Greenblatt would press for urgent turnaround measures.
-4.25%
Negative net income growth while ADI stands at 4.15%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-4.44%
Negative EPS growth while ADI is at 4.35%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-2.27%
Negative diluted EPS growth while ADI is at 4.44%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-1.21%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.72%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.46%
Dividend growth under 50% of ADI's 10.61%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
102.70%
OCF growth above 1.5x ADI's 27.75%. David Dodd would confirm a clear edge in underlying cash generation.
243.37%
FCF growth above 1.5x ADI's 27.44%. David Dodd would verify if the firm’s strategic investments yield superior returns.
91.91%
10Y revenue/share CAGR at 50-75% of ADI's 133.43%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
76.29%
5Y revenue/share CAGR 1.25-1.5x ADI's 59.61%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
17.50%
3Y revenue/share CAGR under 50% of ADI's 44.56%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
123.71%
10Y OCF/share CAGR under 50% of ADI's 379.86%. Michael Burry would worry about a persistent underperformance in cash creation.
171.96%
5Y OCF/share CAGR above 1.5x ADI's 113.64%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-13.46%
Negative 3Y OCF/share CAGR while ADI stands at 38.98%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
311.00%
Below 50% of ADI's 1545.38%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
66.06%
5Y net income/share CAGR at 50-75% of ADI's 121.29%. Martin Whitman might see a shortfall in operational efficiency or brand power.
11.12%
Below 50% of ADI's 45.86%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
100.48%
10Y equity/share CAGR at 75-90% of ADI's 113.48%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
16.45%
Positive 5Y equity/share CAGR while ADI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
5.88%
Positive short-term equity growth while ADI is negative. John Neff sees a strong advantage in near-term net worth buildup.
361.29%
Dividend/share CAGR of 361.29% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
366.79%
Dividend/share CAGR of 366.79% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
652488.96%
3Y dividend/share CAGR above 1.5x ADI's 100.36%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-2.04%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-4.60%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
0.68%
Asset growth well under 50% of ADI's 2.52%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.34%
50-75% of ADI's 3.76%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
3.89%
R&D growth drastically higher vs. ADI's 0.88%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-8.88%
We cut SG&A while ADI invests at 0.56%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.